2,5-dimethoxy-4-bromoamphetamine has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (29.17) | 18.7374 |
| 1990's | 10 (41.67) | 18.2507 |
| 2000's | 6 (25.00) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartyzel, P; Glennon, RA; Leonhardt, S; Raghupathi, R; Teitler, M | 1 |
| Glennon, RA; Lyon, RA; Roth, BL; Seggel, MR; Suba, EA; Titeler, M; Yousif, MY | 1 |
| Glennon, RA; Lyon, RA; McKenney, JD; Titeler, M | 1 |
| Benington, F; Glennon, RA; Morin, RD; Young, R | 1 |
| Frescas, S; Gudelsky, GA; Huang, X; Marona-Lewicka, D; Nash, JF; Nichols, DE; Roth, BL | 1 |
| Mutel, V; Sleight, AJ; Stam, NJ; Vanderheyden, PM | 1 |
| Clare, BW | 1 |
| Glennon, RA; Lucaites, VL; Nelson, DL; Wainscott, DB | 1 |
| Dupre, A; Egan, C; Grinde, E; Hake, M; Herrick-Davis, K; Roth, BL; Teitler, M | 1 |
| Cassels, BK; Castillo, M; Fierro, A; Gallardo-Godoy, A; McLean, TH; Nichols, DE; Reyes-Parada, M | 1 |
| Kurrasch, DM; Nichols, DE; Parker, MA | 1 |
| Glennon, RA; Mosier, PD; Roth, BL; Runyon, SP; Westkaemper, RB | 1 |
| Glennon, RA | 1 |
| Done, CJ; Sharp, T | 1 |
| Breeding, M; Sanders-Bush, E | 1 |
| Ashby, CR; Jiang, LH; Kasser, RJ; Wang, RY | 1 |
| Peroutka, SJ; Pierce, PA | 2 |
| Dimpfel, W; Nichols, DE; Spüler, M | 1 |
| Buckholtz, NS; Freedman, DX; Zhou, DF | 1 |
| McKenna, DJ; Saavedra, JM | 1 |
| Meltzer, HY; Willins, DL | 1 |
| Berg, KA; Cassels, BK; Clarke, WP; Gutiérrez-Hernandez, MA; Moya, PR; Reyes-Parada, M; Sáez-Briones, P | 1 |
| Ewald, AH; Maurer, HH | 1 |
24 other study(ies) available for 2,5-dimethoxy-4-bromoamphetamine and 4-iodo-2,5-dimethoxyphenylisopropylamine
| Article | Year |
|---|---|
Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity.
Topics: Animals; Binding Sites; Binding, Competitive; Ergolines; Ketanserin; Male; Molecular Structure; Propylamines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Structure-Activity Relationship; Tritium | 1992 |
A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors.
Topics: Amphetamines; Animals; In Vitro Techniques; Ketanserin; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Solubility; Structure-Activity Relationship | 1990 |
5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues.
Topics: Animals; Anisoles; Binding, Competitive; Generalization, Stimulus; In Vitro Techniques; Male; Propylamines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Stereoisomerism; Structure-Activity Relationship | 1986 |
Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane.
Topics: Amphetamines; Animals; Behavior, Animal; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; In Vitro Techniques; Isomerism; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1982 |
1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist.
Topics: 3T3 Cells; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Binding, Competitive; Cell Line; Discrimination, Psychological; Frontal Lobe; Hippocampus; Iodine Radioisotopes; Ketanserin; Male; Mice; Phenethylamines; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Tritium | 1994 |
Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
Topics: 3T3 Cells; Animals; Binding, Competitive; Cell Membrane; DOM 2,5-Dimethoxy-4-Methylamphetamine; Humans; Ketanserin; Mice; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Recombinant Proteins; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1996 |
The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens.
Topics: Hallucinogens; Humans; Models, Molecular; Molecular Conformation; Phenethylamines; Quantum Theory | 1998 |
Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.
Topics: Amphetamines; Animals; Cloning, Molecular; Hallucinogens; Humans; Propylamines; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Recombinant Proteins; Serotonin Receptor Agonists; Structure-Activity Relationship | 1999 |
Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.
Topics: Animals; Cell Line; Computer Simulation; GTP-Binding Proteins; Inositol Phosphates; Kinetics; Phosphatidylinositols; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Recombinant Proteins; Serotonin Receptor Agonists; Signal Transduction; Transfection; Tritium | 2000 |
Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
Topics: Animals; Binding Sites; Brain; Clorgyline; Crystallography, X-Ray; In Vitro Techniques; Male; Methylation; Mitochondria; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley | 2005 |
The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands.
Topics: Anthracenes; Catalysis; Hydrophobic and Hydrophilic Interactions; Ligands; Lipids; Molecular Structure; Phenethylamines; Protein Binding; Receptor, Serotonin, 5-HT2A; Serotonin Antagonists; Serotonin Receptor Agonists | 2008 |
Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.
Topics: Animals; Anthracenes; Cattle; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis; Protein Binding; Receptor, Serotonin, 5-HT2A; Sequence Alignment; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship | 2008 |
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin | 2017 |
Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
Topics: Amphetamines; Animals; DOM 2,5-Dimethoxy-4-Methylamphetamine; Electrophysiology; Hippocampus; Male; Neurons; Norepinephrine; p-Chloroamphetamine; Quipazine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Ritanserin; Serotonin Receptor Agonists; Spiperone; Sulpiride | 1992 |
Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Antiparkinson Agents; Cells, Cultured; Choroid Plexus; DOM 2,5-Dimethoxy-4-Methylamphetamine; Epithelial Cells; Ergolines; Hallucinogens; Male; Phosphatidylinositols; Quipazine; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Stereoisomerism | 1991 |
Electrophysiological characterization of 5-hydroxytryptamine2 receptors in the rat medial prefrontal cortex.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; DOM 2,5-Dimethoxy-4-Methylamphetamine; Ergolines; Frontal Lobe; Ketanserin; Magnesium; Male; Pyridazines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Sodium Glutamate; Tetrahydronaphthalenes | 1990 |
Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex.
Topics: Amphetamines; Bromine Radioisotopes; Cerebral Cortex; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; Humans; In Vitro Techniques; Lysergic Acid Diethylamide; N,N-Dimethyltryptamine; Receptors, Neurotransmitter; Receptors, Serotonin | 1989 |
Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain; Central Nervous System Stimulants; DOM 2,5-Dimethoxy-4-Methylamphetamine; Electroencephalography; Evoked Potentials; Hallucinogens; Injections, Intraperitoneal; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred F344; Telemetry | 1989 |
Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
Topics: Amphetamines; Animals; Cerebral Cortex; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Guanosine Triphosphate; In Vitro Techniques; Ketanserin; Lysergic Acid Diethylamide; Phosphatidylinositols; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1988 |
Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors.
Topics: Amphetamines; Animals; Brain; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; Ketanserin; Lysergic Acid Diethylamide; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin | 1988 |
Autoradiography of LSD and 2,5-dimethoxyphenylisopropylamine psychotomimetics demonstrates regional, specific cross-displacement in the rat brain.
Topics: Amphetamines; Animals; Autoradiography; Binding, Competitive; Brain; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; Lysergic Acid Diethylamide; Rats | 1987 |
Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
Topics: Amphetamines; Animals; Behavior, Animal; DOM 2,5-Dimethoxy-4-Methylamphetamine; Frontal Lobe; Male; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists | 1997 |
Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
Topics: Amphetamines; Animals; Arachidonic Acid; Behavior, Animal; CHO Cells; Cricetinae; Cricetulus; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; Humans; Inositol Phosphates; Male; Mescaline; Motor Activity; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Signal Transduction; Transfection | 2007 |
2,5-Dimethoxyamphetamine-derived designer drugs: studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6.
Topics: Algorithms; Amphetamines; Animals; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Designer Drugs; DOM 2,5-Dimethoxy-4-Methylamphetamine; Fluoxetine; Gas Chromatography-Mass Spectrometry; Humans; Hydroxylation; Insecta; Kinetics; Microsomes, Liver; Molecular Structure; Quinidine; Spectrometry, Mass, Electrospray Ionization | 2008 |